Long-term change in the target achievement rate of low-density lipoprotein cholesterol in patients with cardiovascular disease
Juyoung Shin1, 2, Hyuna Lim3, Hun-Sung Kim2, 4
1 Health Promotion Center, 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 3 Amgen Korea Limited, and 4 Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
DOI 10.5414/CP204311
Abstract
Objectives: The goal achievement rate of patients’ low-density lipoprotein cholesterol (LDL-C) levels and prescribing pattern of statin potency should be continuously monitored in a real-world clinical setting. This study aimed to describe the comprehensive status of LDL-C management.
Materials and methods: Patients first diagnosed with cardiovascular diseases (CVDs) between 2009 and 2018 who were followed for 24 months. LDL-C levels, its changes from baseline, and intensity of statin prescribed were evaluated four times during follow-up. Potential factors associated with goal achievement were also identified.
Results: The study included 25,605 patients with CVDs. At diagnosis, the goal achievement rates of the LDL-C level were 58.4, 25.2, and 10.0% for targets of < 100, < 70, and < 55 mg/dL, respectively. The proportion of moderate- and high-intensity statin prescription significantly increased over time (all p < 0.01). Nevertheless, LDL-C levels significantly decreased at 6 months and increased at 12 and 24 months following therapy compared with baseline values. Glomerular filtration rate (GFR) (15 – 29 and < 15 mL/min/1.73m2) and accompanying diabetes mellitus were significantly associated with the goal achievement rate.
Conclusion: Despite the need for active LDL-C management, the goal achievement rate and prescribing pattern were insufficient after 6 months. In cases with severe comorbidities, the goal attainment rate significantly increased; however, a more aggressive statin prescription was needed even in patients without diabetes or with normal GFR. The prescription rate for high-intensity statins increased over time, but was still low. In conclusion, physicians should aggressively prescribe statins to increase the goal achievement rate in patients with CVDs.
Author Details
Authors
Departments
- 1 Health Promotion Center,
- 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,
- 3 Amgen Korea Limited, and
- 4 Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Address
Hun-Sung Kim, MD, PhD
Department of Medical Informatics
College of Medicine
The Catholic University of Korea
222, Banpo-daero, Seocho-gu
Seoul, 06591, Republic of Korea
Email:
[email protected]
Citation
Juyoung Shin, Hyuna Lim, Hun-Sung Kim. Long-term change in the target achievement rate of low-density lipoprotein cholesterol in patients with cardiovascular disease
. 2023;
61:
159-
171.
doi: 10.5414/CP204311.
Pubmed:
https://pubmed.ncbi.nlm.nih.gov/36795613/;
PMID: 36795613.